• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Recognition by HLA-A2-restricted cytotoxic T lymphocytes of endogenously generated and exogenously provided synthetic peptide analogues of the influenza A virus matrix protein.

作者信息

Sauma S Y, Gammon M C, Bednarek M A, Cunningham B, Biddison W E, Hermes J D, Porter G, Tamhankar S, Hawkins J C, Bush B L

机构信息

Merck Research Laboratories, Rahway, NJ 07065.

出版信息

Hum Immunol. 1993 Aug;37(4):252-8. doi: 10.1016/0198-8859(93)90508-x.

DOI:10.1016/0198-8859(93)90508-x
PMID:8300410
Abstract

Experiments were carried out to determine whether complexes between MHC class I molecules and synthetic peptides are representative of those formed under more physiologically relevant conditions, with peptides derived intracellularly from processed antigens. Lysis of cells sensitized with exogenously provided and endogenously generated peptide analogues of the optimal nonameric peptide 58-66 (GILGFVFTL; derived from the influenza virus matrix protein) was compared. Endogenous loading was accomplished by expressing minigene DNA coding for alanine-substituted analogues of peptide 58-66 in HLA-A2-positive cells. Susceptibility to lysis by HLA-A2-restricted, peptide-specific cytotoxic lymphocytes was compared with lysis of cells sensitized with the same synthetic peptides. Although results were quite comparable, differences were observed. The endogenously presented analogues 58-66L60A, G61A, T65A, and L66A were recognized more efficiently than the corresponding exogenously presented analogues. This difference in recognition was most striking for peptide 58-66G61A. These results indicate the need for caution in using synthetic peptides in defining peptide binding motifs. Additional experiments with endogenously expressed analogues of 58-66 with substitutions other than alanine were carried out to define the interaction between this peptide and HLA-A2. Results are compatible with the interpretation that residues 58, 59, and 60 interact with pockets A, B, and D, respectively, in the HLA-A2 binding groove and that these interactions contribute to peptide binding.

摘要

相似文献

1
Recognition by HLA-A2-restricted cytotoxic T lymphocytes of endogenously generated and exogenously provided synthetic peptide analogues of the influenza A virus matrix protein.
Hum Immunol. 1993 Aug;37(4):252-8. doi: 10.1016/0198-8859(93)90508-x.
2
Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes.通过细胞毒性T淋巴细胞检测抗HLA - A2抗体增强肽与HLA - A2的结合。
Nature. 1989 Nov 23;342(6248):443-6. doi: 10.1038/342443a0.
3
Endogenous loading of HLA-A2 molecules with an analog of the influenza virus matrix protein-derived peptide and its inhibition by an exogenous peptide antagonist.
J Immunol. 1992 Jan 1;148(1):7-12.
4
Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes.甲型流感病毒基质蛋白九聚体肽的鉴定及HLA - A2口袋在细胞毒性T淋巴细胞识别该肽中的作用。
Eur J Immunol. 1992 Apr;22(4):903-7. doi: 10.1002/eji.1830220404.
5
Genetic evidence for difference between intracellular and extracellular peptides in influenza A matrix peptide-specific CTL recognition.甲型流感病毒基质肽特异性CTL识别中细胞内和细胞外肽差异的遗传学证据。
J Immunol. 1995 Feb 1;154(3):1088-96.
6
Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells.内源性肽在转运缺失突变体T2细胞中向MHC I类限制性细胞毒性T淋巴细胞的呈递。
J Immunol. 1993 Mar 1;150(5):1763-71.
7
Residues outside of the HLA-A2 peptide-binding groove can abrogate or enhance recognition of influenza virus matrix peptide pulsed cells by cytotoxic T lymphocytes.HLA - A2肽结合槽外的残基可消除或增强细胞毒性T淋巴细胞对流感病毒基质肽脉冲细胞的识别。
Mol Immunol. 1994 Apr;31(6):445-57. doi: 10.1016/0161-5890(94)90064-7.
8
Mutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptide.HLA - A2的α2螺旋中的突变影响抗原呈递,但不抑制流感病毒基质肽的结合。
J Exp Med. 1988 Aug 1;168(2):725-36. doi: 10.1084/jem.168.2.725.
9
Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes.鉴定可能触发HLA - A2.1限制性细胞毒性T淋巴细胞的肽序列。
Eur J Immunol. 1993 Jun;23(6):1215-9. doi: 10.1002/eji.1830230603.
10
Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis.具有内质网信号序列的内源性合成肽使抗原加工突变细胞对I类限制性细胞介导的裂解敏感。
J Exp Med. 1991 Aug 1;174(2):489-92. doi: 10.1084/jem.174.2.489.

引用本文的文献

1
The androgen receptor: a biologically relevant vaccine target for the treatment of prostate cancer.雄激素受体:治疗前列腺癌的具有生物学相关性的疫苗靶标。
Cancer Immunol Immunother. 2013 Mar;62(3):585-96. doi: 10.1007/s00262-012-1363-9. Epub 2012 Oct 30.
2
Vaccines targeting the cancer-testis antigen SSX-2 elicit HLA-A2 epitope-specific cytolytic T cells.针对癌症睾丸抗原 SSX-2 的疫苗可引发 HLA-A2 表位特异性细胞毒性 T 细胞。
J Immunother. 2011 Oct;34(8):569-80. doi: 10.1097/CJI.0b013e31822b5b1d.
3
CD8+ T cells specific for the androgen receptor are common in patients with prostate cancer and are able to lyse prostate tumor cells.
针对雄激素受体的 CD8+ T 细胞在前列腺癌患者中很常见,并且能够裂解前列腺肿瘤细胞。
Cancer Immunol Immunother. 2011 Jun;60(6):781-92. doi: 10.1007/s00262-011-0987-5. Epub 2011 Feb 25.
4
Attenuated Listeria monocytogenes vaccine vectors expressing influenza A nucleoprotein: preclinical evaluation and oral inoculation of volunteers.表达甲型流感核蛋白的减毒李斯特菌疫苗载体:临床前评估和志愿者口服接种。
Microbiol Immunol. 2011 May;55(5):304-17. doi: 10.1111/j.1348-0421.2011.00322.x.
5
HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase.针对前列腺酸性磷酸酶的 HLA-A2 限制性 T 细胞表位。
Cancer Immunol Immunother. 2010 Jun;59(6):943-53. doi: 10.1007/s00262-010-0820-6. Epub 2010 Feb 6.
6
Comprehensive epitope mapping of the Epstein-Barr virus latent membrane protein-2 in normal, non tumor-bearing individuals.在正常、无肿瘤个体中对爱泼斯坦-巴尔病毒潜伏膜蛋白2进行全面的表位作图。
Cancer Immunol Immunother. 2007 Jul;56(7):1047-63. doi: 10.1007/s00262-006-0246-3. Epub 2006 Nov 24.
7
Pilot study of an HLA-A2 peptide vaccine using flt3 ligand as a systemic vaccine adjuvant.一项使用Flt3配体作为全身疫苗佐剂的HLA - A2肽疫苗的初步研究。
J Clin Immunol. 2003 Jan;23(1):62-72. doi: 10.1023/a:1021904432489.
8
Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients.用HER-2/neu辅助肽疫苗进行免疫接种可在癌症患者中产生HER-2/neu CD8 T细胞免疫。
J Clin Invest. 2001 Feb;107(4):477-84. doi: 10.1172/JCI11752.